Lifecore Biomedical to Report Financial Results for Third Quarter of Fiscal 2025 on April 3, 2025
Rhea-AI Summary
Lifecore Biomedical (NASDAQ: LFCR), a contract development and manufacturing organization (CDMO), has scheduled its third quarter fiscal 2025 financial results announcement for Thursday, April 3, 2025, after market close.
The company's senior management team will host a webcast at 4:30 p.m. Eastern Time to discuss the quarterly results and recent corporate developments. The webcast will be accessible through Lifecore's Investor Events & Presentations webpage, with an archived version available for 30 days following the live presentation.
Positive
- None.
Negative
- None.
Webcast Scheduled for Thursday, April 3 at 4:30 p.m. Eastern
CHASKA, Minn., March 27, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it will report financial results for the third quarter of fiscal year 2025 on Thursday, April 3, 2025, after market close. At 4:30 p.m. Eastern Time that day, members of Lifecore’s senior management team will host a webcast to discuss financial results for the quarter and review recent corporate developments.
To listen to the live webcast, or access the archived webcast, please visit the Investor Events & Presentations page of Lifecore’s website at: https://ir.lifecore.com/events-presentations. Following the live webcast, an archived version of the webcast will be available on the company’s website for 30 days.
About Lifecore Biomedical
Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.
Lifecore Biomedical, Inc. Contact Information: Vida Strategic Partners Stephanie Diaz (Investors) 415-675-7401 sdiaz@vidasp.com Tim Brons (Media) 415-675-7402 tbrons@vidasp.com Ryan D. Lake (CFO) Lifecore Biomedical 952-368-6244 ryan.lake@lifecore.com
FAQ
When will Lifecore Biomedical (LFCR) release Q3 2025 earnings?
What time is Lifecore Biomedical's (LFCR) Q3 2025 earnings call?
How long will LFCR's Q3 2025 earnings webcast recording be available?
Where can I access Lifecore Biomedical's (LFCR) Q3 2025 earnings webcast?
